Does interaction of RAS activation and lipid disorders accelerate the progression of glomerulosclerosis?
This study demonstrates that the interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis.
IOM was associated with better clinical outcomes and some increased hospital charges among discharges of simple spinal fusions and laminectomies in a large, multiyear, nationally representative dataset.